Spots Global Cancer Trial Database for Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

Official Title: A Multicenter Randomized Phase II Trial in NSCLC Stage IV et IIIB in Elderly Dependent Patients With Evaluation of the Sequence Gemcitabine First Line Followed by Erlotinib When Progression Versus Erlotinib First Line Followed by Gemcitabine When Progression.

Study ID: NCT00419042

Conditions

Non Small Cell Lung Cancer

Interventions

TARCEVA

Gemzar

Study Description

Brief Summary: The purpose of this study is in non small-cell lung cancer stage IV et IIIB (T4 with pleural effusion) in elderly dependent patients with evaluation of the sequence Gemcitabine first line followed by Erlotinib when progression versus Erlotinib first line followed by Gemcitabine when progression

Detailed Description: A multicenter phase II trial,prospective,randomized,open,non comparative